19 18 4 . . . . , . . , . SUPERB . . () [] 1.5mm 60~70 . , , , , , . , , , . , . . . 0 .
[ ]2022 3 . , , . B . A+() 10 B . B1, B2, B6 , , , , , , . B1 . B1 8, B1 4 . . A+ D, , . ikson@heraldcorp.com
, ) , [ ] (VectorBuilder) (Lantu Biopharma) . (AAV) AAV , AAV CRO() CDMO() . ATP7A . 3 . . . . . LTGT06 , . (Bruce Lahn) " " .
874 7% 17 . 55, 20 .855, 58, 27 ., (ETC) . ." · " " Q, 'WE VALUE' " ." , " " " .[ ][ & mk.co.kr, ] Copyright MBN()
40 . [=Staras/] . , . (1 , , ) . , . . . . . 49.9, 40 . 2009~2018 30 140 1175 , 2%(2 8111) 40 . 36.7. . , 33%, 9% . 45~49, 40~44, 40 50 11%, 23%, 39%, 4%, 10%, 11% . . “ ” “ , , ” . … [+80 chars]
, . . (Set Point) . 50kg 55kg . , . , . . , , . . . , . . . , , . . . . , . . , . , , , , . . < > , . , . . , . . . , · ?, . · . , . , , , . . 14 . , . 1~2 24 . = , < >,
ö .ó 5(2017~2021) ü 39.5% 7~10 . , 19.0%, 16.5%, 13.2%, 12.1% .. µ . . , , , , õ . , , , , , . ð â ( ) " µ ö " " õ " ." " " " . õ . ö , õ . µ û° 3~4 . . ù ù .bellho@sportschosun.com
SPARC . [=] . SPARC(Secreted Protein Acidic and Rich in Cysteine) . (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy; CALERIE) . 2 14% , . 1 2 , , , SPARC . . SPA… [+223 chars]
.5(2017~2021) 39.5% 7~10 . , 19.0%, · 16.5%, 13.2%, 12.1% . . .. , , , , . , , , , , .( ) " " " " . " " " " . . , . 3~4 . . . bellho@sportschosun.com
() . 246 . 17 (The Department of Health) AISR(Australian Influenza Surveillance Report, ) . (NNDSS, National Notifiable Diseases Surveillance System) (ILI, ) 212573. 2606 0.8% 2 . 7 31 5~9 ,… [+431 chars]
[ ]19 ( ) . 19 . , . . , 3 . 1 . 2, 3 .[] 100...19 60% 17 19 , 2020 12 330 ( 389400) . , HPV, B , (HIV), , , , , . HPV B , . 2020 70 . (43 ), HPV (41 ), (40 ) . 2021 19 656 ( 75) . 1000 (100)… [+435 chars]
.· . , 2017 906631 2021 1126861 . 50 40%, 10% . . . . . , . , . , . . . 45%, 34%, 20% .. ' ' . . . , . . . . 50 . . . 3 . " , " " , D " . D . . , . . . . . D , D , . D , . . , . … [+22 chars]
